Members |
targetComponentId |
Illegal abortion with laceration of cervix |
Induced termination of pregnancy complicated by laceration of cervix |
Illegal abortion with laceration of periurethral tissue |
Induced termination of pregnancy complicated by laceration of periurethral tissue |
Illegal abortion with laceration of uterus |
Induced termination of pregnancy complicated by laceration of uterus |
Illegal abortion with laceration of vagina |
Induced termination of pregnancy complicated by laceration of vagina |
Illegal abortion with oliguria |
Induced termination of pregnancy complicated by oliguria |
Illegal abortion with parametritis |
Induced termination of pregnancy complicated by parametritis (disorder) |
Illegal abortion with pelvic peritonitis |
Induced termination of pregnancy complicated by pelvic peritonitis (disorder) |
Illegal abortion with perforation of bladder |
Induced termination of pregnancy complicated by perforation of urinary bladder |
Illegal abortion with perforation of bowel |
Induced termination of pregnancy complicated by perforation of bowel (disorder) |
Illegal abortion with perforation of broad ligament |
Induced termination of pregnancy complicated by perforation of broad ligament |
Illegal abortion with perforation of cervix |
Induced termination of pregnancy complicated by perforation of cervix (disorder) |
Illegal abortion with perforation of periurethral tissue |
Induced termination of pregnancy complicated by perforation of periurethral tissue |
Illegal abortion with perforation of uterus |
Induced termination of pregnancy complicated by perforation of uterus |
Illegal abortion with perforation of vagina |
Induced termination of pregnancy complicated by perforation of vagina (disorder) |
Illegal abortion with postoperative shock |
Induced termination of pregnancy complicated by postoperative shock |
Illegal abortion with pulmonary embolism |
Induced termination of pregnancy complicated by pulmonary embolism |
Illegal abortion with pyemic embolism |
Induced termination of pregnancy complicated by septic embolism (disorder) |
Illegal abortion with renal tubular necrosis |
Induced termination of pregnancy complicated by renal tubular necrosis |
Illegal abortion with salpingitis |
Induced termination of pregnancy complicated by salpingitis (disorder) |
Illegal abortion with salpingo-oophoritis |
Induced termination of pregnancy complicated by salpingo-oophoritis (disorder) |
Illegal abortion with sepsis |
Sepsis following induced termination of pregnancy (disorder) |
Illegal abortion with septic embolism |
Induced termination of pregnancy complicated by septic embolism (disorder) |
Illegal abortion with septic shock |
Induced termination of pregnancy complicated by septic shock |
Illegal abortion with septicemia |
Sepsis following induced termination of pregnancy (disorder) |
Illegal abortion with soap embolism |
Induced termination of pregnancy complicated by soap embolism |
Illegal abortion with specified complication, NEC |
Induced termination of pregnancy (procedure) |
Illegal abortion with uremia |
Induced termination of pregnancy complicated by uraemia |
Illegal abortion with urinary tract infection |
Induced termination of pregnancy complicated by urinary tract infection |
Illegal abortion without complication |
Termination of pregnancy |
Illegally induced abortion |
Termination of pregnancy |
Illegally induced abortion |
Termination of pregnancy |
Illegally induced abortion NOS |
Termination of pregnancy |
Illegitimate brother |
Sibling |
Illegitimate child |
Child |
Illegitimate daughter |
Daughter |
Illegitimate sibling |
Sibling |
Illegitimate sister |
Sister |
Illegitimate son |
Son |
Iloprost 100micrograms/mL infusion concentrate 1mL ampule |
Iloprost (as iloprost trometamol) 100 microgram/mL solution for injection |
Iloprost 10mcg/mL nebulizer solution 1mL ampule |
Product containing precisely iloprost (as iloprost trometamol) 10 microgram/1 milliliter conventional release solution for nebulizer (clinical drug) |
Iloprost 10mcg/mL nebulizer solution 2mL ampule |
Product containing precisely iloprost (as iloprost trometamol) 10 microgram/1 milliliter conventional release solution for nebulizer (clinical drug) |
Imaging by body site |
Imaging (procedure) |
Imam |
Muslim prayer leader |
Imatinib 100mg capsule |
Product containing precisely imatinib (as imatinib mesilate) 100 milligram/1 each conventional release oral capsule (clinical drug) |
Imatinib mesylate 100mg capsule |
Product containing precisely imatinib (as imatinib mesilate) 100 milligram/1 each conventional release oral capsule (clinical drug) |
Imatinib mesylate 400mg capsule |
Imatinib (as imatinib mesilate) 400 mg oral capsule |
Imidapril hydrochloride |
Product containing imidapril (medicinal product) |
Imidazole acetic acid |
Imidazole |
Imiglucerase 200unt injection |
Imiglucerase 200 unit powder for solution for injection vial |
Imiglucerase 400u powder for infusion solution vial |
Imiglucerase 400 unit powder for solution for injection vial |
Imipenem 500mg/cilastatin 500mg powder for infusion solution transfer vial |
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem 500 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
Imipenem 500mg/cilastatin 500mg powder for infusion solution vial |
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem anhydrous (as imipenem) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Imipenem 750mg/cilastatin 750mg powder for injection solution vial |
Product containing only cilastatin and imipenem in parenteral dose form (medicinal product form) |
Immature white blood cells NOS |
Immature white blood cells |
Immature white blood cells NOS |
Immature white blood cells |
Immediate operation NOC |
Intentional, structural alteration of the human body by mechanical, thermal, light-based, electromagnetic, or chemical means, and/or by the incision or destruction of tissues using instruments to cut, burn, vaporize, freeze, suture, probe, or manipulate by closed reductions. |
Immediate repair of obstetric laceration NOS |
Immediate repair of obstetric laceration (procedure) |
Immediate repair of obstetric laceration of uterus or cervix uteri |
Immediate repair of obstetric laceration of cervix uteri (procedure) |
Immersion, unspecified |
Immersion (disorder) |
Immobilisation and support NOS |
Procedures relating to splintage and immobilisation |
Immobilisation by cast NOS |
Immobilization using plaster cast |
Immobilise by splinting NOS |
Immobilisation by splinting |
Immobilization and support NOS |
Procedures relating to splintage and immobilisation |
Immobilization by cast NOS |
Immobilization using plaster cast |
Immobilize by splinting NOS |
Immobilisation by splinting |
Immune enhancement agent |
Immune enhancement agent (substance) |
Immune system observation |
Immune system finding |
Immune thrombocytopenic purpura |
Immune thrombocytopenia |
Immune thrombocytopenic purpura |
An autoimmune coagulation disorder characterized by isolated thrombocytopenia (a platelet count <100,000/microL), in the absence of any underlying disorder that may be associated with thrombocytopenia. |
Immunisation screening NOS |
Immunisation status screening |
Immunization screening NOS |
Immunization status |
Immunodeficiency with multicarboxylase deficiency |
A group of inborn errors of biotin metabolism characterized by reduced activities of biotin-dependent enzymes resulting in a wide spectrum of symptoms, including feeding difficulty, breathing difficulties, lethargy, seizures, skin rash, alopecia, and developmental delay. This group includes biotinidase deficiency and biotin holocarboxylase synthetase deficiency. |
Immunoelectrophoresis NOS |
Immunoelectrophoresis |
Immunoelectrophoresis NOS |
Immunoelectrophoresis |
Immunoglobulins NOS |
Immunoglobulin measurement (procedure) |
Immunoglobulins NOS |
Immunoglobulin measurement (procedure) |
Immunologic agent |
Immunologic agent (substance) |
Immunologic paralysis |
Immunologic tolerance |
Immunologic unresponsiveness |
Immunologic tolerance |
Immunological therapy NOS |
Immunological therapy |
Immunological therapy NOS |
Immunological therapy |
Immunology NOS |
Immunology laboratory test |
Immunology NOS |
Immunology laboratory test |
Immunology NOS |
Immunology laboratory test |
Immunology NOS |
Immunology laboratory test |
Immunoproliferative disease - morphology |
Immunoproliferative disease (morphologic abnormality) |
Immunoproliferative disease, no International Classification of Diseases for Oncology subtype |
Immunoproliferative disease (morphologic abnormality) |
Immunotherapeutic agent |
Immunologic agent (substance) |
Immunotherapy for cancer |
Immunological therapy |
Impacted twins |
Interlocked twins |
Impaired glucose tolerance associated with unlisted conditions |
Impaired glucose tolerance |
Impaired renal function disorder NOS |
Renal impairment |
Imperforate left ventriculoarterial valve |
Congenital atresia of aortic valve (disorder) |
Imperforate right ventriculoarterial valve |
Congenital atresia of pulmonary valve |
Impersonal environment |
Impersonal environment (finding) |
Impervious urethra |
Congenital stricture of urethra |
Implant |
Implant |
Implant-related action |
To put in between or into a part(s) of the body. |
Implantable electrical stimulation system interoperative test lead |
Implantable electrical stimulation system intraoperative test lead |
Implantation as cylinder |
To put in between or into a part(s) of the body. |
Implantation of inert material in orbit |
The act of fixing something firmly or setting something securely or deeply into the body. |